These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15588981)

  • 1. Small molecule approach to studying protein tyrosine phosphatase.
    Kumar S; Liang F; Lawrence DS; Zhang ZY
    Methods; 2005 Jan; 35(1):9-21. PubMed ID: 15588981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allele-specific inhibitors of protein tyrosine phosphatases.
    Hoffman HE; Blair ER; Johndrow JE; Bishop AC
    J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the development of small molecule inhibitors of PTP1B for the treatment of insulin resistance and type 2 diabetes.
    Tobin JF; Tam S
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):500-12. PubMed ID: 12197308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor and nonreceptor protein tyrosine phosphatases in the nervous system.
    Paul S; Lombroso PJ
    Cell Mol Life Sci; 2003 Nov; 60(11):2465-82. PubMed ID: 14625689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate.
    Lee H; Xie L; Luo Y; Lee SY; Lawrence DS; Wang XB; Sotgia F; Lisanti MP; Zhang ZY
    Biochemistry; 2006 Jan; 45(1):234-40. PubMed ID: 16388599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyrtiosal, a PTP1B inhibitor from the marine sponge Hyrtios erectus, shows extensive cellular effects on PI3K/AKT activation, glucose transport, and TGFbeta/Smad2 signaling.
    Sun T; Wang Q; Yu Z; Zhang Y; Guo Y; Chen K; Shen X; Jiang H
    Chembiochem; 2007 Jan; 8(2):187-93. PubMed ID: 17183521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
    Stuible M; Zhao L; Aubry I; Schmidt-Arras D; Böhmer FD; Li CJ; Tremblay ML
    Chembiochem; 2007 Jan; 8(2):179-86. PubMed ID: 17191286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of small interference RNA against PTP1B and TCPTP on insulin signaling pathway in mouse liver: evidence for non-synergetic cooperation.
    Xu J; Li L; Hong J; Huang W
    Cell Biol Int; 2007 Jan; 31(1):88-91. PubMed ID: 17088077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
    Koren S; Fantus IG
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enzyme-linked immunosorbent assay to measure insulin receptor dephosphorylation by PTP1B.
    Zhang YL; Tam M; Kirincich S; Wan ZK; Wilson D; Wu JJ; Lee J; Tobin JF; Erbe DV
    Anal Biochem; 2007 Jun; 365(2):174-84. PubMed ID: 17481567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose enhances protein tyrosine phosphatase 1B gene transcription in hepatocytes.
    Inada S; Ikeda Y; Suehiro T; Takata H; Osaki F; Arii K; Kumon Y; Hashimoto K
    Mol Cell Endocrinol; 2007 Jun; 271(1-2):64-70. PubMed ID: 17509747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical and mechanistic approaches to the study of protein tyrosine phosphatases.
    Zhang ZY
    Acc Chem Res; 2003 Jun; 36(6):385-92. PubMed ID: 12809524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gatekeeper residue for inhibitor sensitization of protein tyrosine phosphatases.
    Bishop AC; Blair ER
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4002-6. PubMed ID: 16716588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
    Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
    Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic approaches to studying protein tyrosine phosphatases.
    Liang F; Kumar S; Zhang ZY
    Mol Biosyst; 2007 May; 3(5):308-16. PubMed ID: 17460790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease.
    Doody KM; Bourdeau A; Tremblay ML
    Immunol Rev; 2009 Mar; 228(1):325-41. PubMed ID: 19290937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
    Zhang S; Zhang ZY
    Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chemical model for redox regulation of protein tyrosine phosphatase 1B (PTP1B) activity.
    Sivaramakrishnan S; Keerthi K; Gates KS
    J Am Chem Soc; 2005 Aug; 127(31):10830-1. PubMed ID: 16076179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6,8-Difluoro-4-methylumbiliferyl phosphate: a fluorogenic substrate for protein tyrosine phosphatases.
    Welte S; Baringhaus KH; Schmider W; Müller G; Petry S; Tennagels N
    Anal Biochem; 2005 Mar; 338(1):32-8. PubMed ID: 15707933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of PTP1B by RNAi upregulates the activity of insulin controlled fatty acid synthase promoter.
    Xu J; Li L; Qian Z; Hong J; Shen S; Huang W
    Biochem Biophys Res Commun; 2005 Apr; 329(2):538-43. PubMed ID: 15737620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.